Literature DB >> 2586550

Inhibition of the adaptive response of human lymphocytes to very low doses of ionizing radiation by the protein synthesis inhibitor cycloheximide.

J H Youngblom1, J K Wiencke, S Wolff.   

Abstract

When human lymphocytes are preirradiated with 1 cGy of X-rays, the cells become less sensitive to subsequent exposures to high doses of about 150 cGy in that approximately one-half as many chromatid aberrations are induced as expected. This adaptation has been attributed to the induction of repair enzymes (proteins) some 4-6 h after the initial low-dose exposure. Experiments have now been carried out showing that application of the protein synthesis inhibitor cycloheximide at this time, but not earlier, prevents the adaptive response.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2586550     DOI: 10.1016/0165-7992(89)90107-3

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  25 in total

1.  Low doses of radiation are protective in vitro and in vivo: evolutionary origins.

Authors:  R E J Mitchel
Journal:  Dose Response       Date:  2006-08-19       Impact factor: 2.658

2.  Will radiation-induced bystander effects or adaptive responses impact on the shape of the dose response relationships at low doses of ionizing radiation?

Authors:  William F Morgan
Journal:  Dose Response       Date:  2006-08-25       Impact factor: 2.658

3.  Radiomodification of glyoxalase I in the liver and spleen of mice: adaptive response and split-dose effect.

Authors:  A B Tiku; R K Kale
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

4.  Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay.

Authors:  Steven M Bryce; Derek T Bernacki; Jeffrey C Bemis; Richard A Spellman; Maria E Engel; Maik Schuler; Elisabeth Lorge; Pekka T Heikkinen; Ulrike Hemmann; Véronique Thybaud; Sabrina Wilde; Nina Queisser; Andreas Sutter; Andreas Zeller; Melanie Guérard; David Kirkland; Stephen D Dertinger
Journal:  Environ Mol Mutagen       Date:  2017-04       Impact factor: 3.216

Review 5.  Radioadaptive response revisited.

Authors:  Soile Tapio; Vesna Jacob
Journal:  Radiat Environ Biophys       Date:  2006-11-28       Impact factor: 1.925

6.  Predictions of genotoxic potential, mode of action, molecular targets, and potency via a tiered multiflow® assay data analysis strategy.

Authors:  Stephen D Dertinger; Andrew R Kraynak; Ryan P Wheeldon; Derek T Bernacki; Steven M Bryce; Nikki Hall; Jeffrey C Bemis; Sheila M Galloway; Patricia A Escobar; George E Johnson
Journal:  Environ Mol Mutagen       Date:  2019-02-27       Impact factor: 3.216

7.  Adaptive doses of irradiation-an approach to a new therapy concept for bladder cancer?

Authors:  Moshe Schaffer; Silke B Schwarz; Ulrike Kulka; Martin Busch; Eckhart Dühmke
Journal:  Radiat Environ Biophys       Date:  2004-09-29       Impact factor: 1.925

8.  γH2AX and p53 responses in TK6 cells discriminate promutagens and nongenotoxicants in the presence of rat liver S9.

Authors:  Derek T Bernacki; Steven M Bryce; Jeffrey C Bemis; David Kirkland; Stephen D Dertinger
Journal:  Environ Mol Mutagen       Date:  2016-07-01       Impact factor: 3.216

9.  Maintenance of manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by repeated administration of the free thiol form of amifostine.

Authors:  Jeffrey S Murley; Danupon Nantajit; Kenneth L Baker; Yasushi Kataoka; Jian Jian Li; David J Grdina
Journal:  Radiat Res       Date:  2008-05       Impact factor: 2.841

10.  Genotoxic mode of action predictions from a multiplexed flow cytometric assay and a machine learning approach.

Authors:  Steven M Bryce; Derek T Bernacki; Jeffrey C Bemis; Stephen D Dertinger
Journal:  Environ Mol Mutagen       Date:  2016-01-13       Impact factor: 3.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.